Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACT-PAD: Chelation Therapy in Diabetic Patients With Critical Limb Ischemia
NCT03424746Phase 1Completed
- Sponsor
- Mount Sinai Medical Center
- Start
- Aug 2015
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of edetate disodium in critical limb ischemia (CLI) and Peripheral Arterial Disease (PAD), sponsored by Mount Sinai Medical Center. Primary endpoints: Improvement in vascular flow parameters at 1 year, Wound Evaluation at 1 year and 6 more. Started Aug 2015; status: completed.
02
Drugs
edetate disodium
03
Conditions
critical limb ischemia (CLI)Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT03424746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03424746.